A few decades ago, nobody really questioned vaccines. They were viewed as a standard part of staying healthy and safe. Today, the number of people questioning vaccines risks prolonging a pandemic that has already killed hundreds of thousands of Americans. How we got to this moment didn’t start with the rollout of vaccines or in March 2020, or even with the election of Donald Trump. Our confidence in vaccines, often isn't even about vaccines. It’s about trust. And that trust has been eroding for a long time. Doubt, a new series from Bloomberg’s Prognosis podcast, looks at the forces that have been breaking down that trust. We'll trace the rise of vaccine skepticism in America to show how we got here — and where we’re going. Doubt launches on March 23. Subscribe to Prognosis today on Apple Podcasts, Spotify or wherever you get your podcasts.
See omnystudio.com/listener for privacy information.
21: End of the Road for Bill Ackman and Canadian Pacific
20: Will Alaska's Virgin Acquisition Go Bust?
19: From Banker to Teacher to ... Something in Between
17: Why Chinese Companies Are `Homewreckers' on U.S. M&A Deals
My Three Decades in M&A
Episode 16: How to Make Money from M&A
Episode 15: Perils and Prizes of Latin American Investing
Episode 14: Charter Was `Blindsided' by Comcast's Offer for TWC
Episode 13: The Female Founders Fund
Episode 12: Loving George Steinbrenner's Wrath
Episode 11: JPMorgan M&A Chairman Kurt Simon Gets Personal
Episode 10: Are Private Equity Deals in Trouble?
Episode 9: Controlling the M&A Story
Episode 8: Private Equity Deals Aren't Just About Slashing Jobs
Episode 7: Inside The Lives of M&A Reporters
Episode 6: M&A Year Ahead
Episode 5: Greenhill CEO Scott Bok on Activist Investors
Episode 4: 2016’s Top Five Predictions
Episode 3: Has Tech M&A Reached Its Peak?
Episode 2: Pfizer Sticks It to U.S. Treasury
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
Masters in Business
Odd Lots
Bloomberg Surveillance
Bloomberg Businessweek
Prognosis: Losing it